Adham S. Bear

2.1k total citations · 1 hit paper
25 papers, 1.5k citations indexed

About

Adham S. Bear is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Adham S. Bear has authored 25 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 17 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Adham S. Bear's work include CAR-T cell therapy research (15 papers), Immunotherapy and Immune Responses (14 papers) and T-cell and B-cell Immunology (6 papers). Adham S. Bear is often cited by papers focused on CAR-T cell therapy research (15 papers), Immunotherapy and Immune Responses (14 papers) and T-cell and B-cell Immunology (6 papers). Adham S. Bear collaborates with scholars based in United States and France. Adham S. Bear's co-authors include Robert H. Vonderheide, Mark H. O’Hara, Aaron E. Foster, Cliona M. Rooney, Malcolm K. Brenner, An Lu, John Craddock, Martin Pulé, Rebekah A. Drezek and Adam Yuh Lin and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Immunology.

In The Last Decade

Adham S. Bear

24 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Challenges and Opportunities for Pancreatic Cancer Immunotherapy

2020 398 citations Adham S. Bear, Robert H. Vonderheide et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adham S. Bear United States	13	964	643	500	483	217	25	1.5k
Karlo Perica United States	17	1.1k 1.2×	1.1k 1.7×	513 1.0×	600 1.2×	129 0.6×	29	2.0k
Sarah Ahn United States	11	796 0.8×	514 0.8×	786 1.6×	408 0.8×	209 1.0×	15	1.4k
Yao Xu United States	17	561 0.6×	1.6k 2.5×	1.0k 2.1×	1.0k 2.1×	108 0.5×	32	2.5k
Jiaqiang Ren United States	26	635 0.7×	443 0.7×	318 0.6×	741 1.5×	177 0.8×	50	1.9k
Biagio De Angelis Italy	22	1.2k 1.2×	774 1.2×	326 0.7×	543 1.1×	352 1.6×	44	1.7k
Libo Zhou China	17	148 0.2×	728 1.1×	374 0.7×	474 1.0×	172 0.8×	42	1.7k
Huizi Sha China	17	401 0.4×	277 0.4×	309 0.6×	577 1.2×	123 0.6×	41	1.1k
Liquan Gao United Kingdom	21	782 0.8×	1.1k 1.6×	436 0.9×	574 1.2×	212 1.0×	31	1.9k
Neil C. Sheppard United States	16	441 0.5×	481 0.7×	395 0.8×	488 1.0×	157 0.7×	32	1.2k

Countries citing papers authored by Adham S. Bear

Since Specialization

Citations

This map shows the geographic impact of Adham S. Bear's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adham S. Bear with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adham S. Bear more than expected).

Fields of papers citing papers by Adham S. Bear

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adham S. Bear. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adham S. Bear. The network helps show where Adham S. Bear may publish in the future.

Co-authorship network of co-authors of Adham S. Bear

This figure shows the co-authorship network connecting the top 25 collaborators of Adham S. Bear. A scholar is included among the top collaborators of Adham S. Bear based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adham S. Bear. Adham S. Bear is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Jia‐Geng, Mathilde Poussin, Madhara Udawela, et al.. (2025). Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy. Cancer Cell. 43(7). 1365–1376.e5. 4 indexed citations

Linette, Gerald P., Adham S. Bear, & Beatriz M. Carreno. (2024). Facts and Hopes in Immunotherapy Strategies Targeting Antigens Derived from KRAS Mutations. Clinical Cancer Research. 30(10). 2017–2024. 6 indexed citations

Wellhausen, Nils, Nils W. Engel, January Salas-McKee, et al.. (2024). Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors. Cancer Immunology Research. 12(9). 1136–1146. 2 indexed citations

Bear, Adham S., Mark H. O’Hara, Chong Xu, et al.. (2024). Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumors. Journal of Clinical Investigation. 134(21). 12 indexed citations

Bear, Adham S., Tatiana Blanchard, Michael Ford, et al.. (2021). Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting. Nature Communications. 12(1). 4365–4365. 73 indexed citations

Bear, Adham S., Robert H. Vonderheide, & Mark H. O’Hara. (2020). Challenges and Opportunities for Pancreatic Cancer Immunotherapy. Cancer Cell. 38(6). 788–802. 398 indexed citations breakdown →

Vonderheide, Robert H. & Adham S. Bear. (2020). Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic Cancer. Frontiers in Immunology. 11. 605619–605619. 30 indexed citations

Bear, Adham S., Andrew J. Rech, Lee P. Richman, et al.. (2019). Abstract B04: Identification of T-cell receptors targeting mutant KRAS in pancreatic cancer. Cancer Research. 79(24_Supplement). B04–B04. 1 indexed citations

Galvan, Daniel L., Richard T. O’Neil, Aaron E. Foster, et al.. (2015). Anti-Tumor Effects after Adoptive Transfer of IL-12 Transposon-Modified Murine Splenocytes in the OT-I-Melanoma Mouse Model. PLoS ONE. 10(10). e0140744–e0140744. 8 indexed citations

10.

Bear, Adham S., Patrick J. Hanley, Doyle Bosque, et al.. (2014). Low rate of infusional toxicity after expanded cord blood transplantation. Cytotherapy. 16(8). 1153–1157. 6 indexed citations

11.

Lin, Adam Yuh, Adham S. Bear, Joseph K. Young, et al.. (2013). High-density sub-100-nm peptide-gold nanoparticle complexes improve vaccine presentation by dendritic cells in vitro. Nanoscale Research Letters. 8(1). 72–72. 65 indexed citations

12.

Bear, Adham S., Laura C. Kennedy, Joseph K. Young, et al.. (2013). Elimination of Metastatic Melanoma Using Gold Nanoshell-Enabled Photothermal Therapy and Adoptive T Cell Transfer. PLoS ONE. 8(7). e69073–e69073. 134 indexed citations

13.

Lin, Adam Yuh, Joao Paulo Mattos Almeida, Adham S. Bear, et al.. (2013). Gold Nanoparticle Delivery of Modified CpG Stimulates Macrophages and Inhibits Tumor Growth for Enhanced Immunotherapy. PLoS ONE. 8(5). e63550–e63550. 135 indexed citations

14.

Woodard, Lauren E., et al.. (2013). An adaptable system for improving transposon‐based gene expression in vivo via transient transgene repression. The FASEB Journal. 27(9). 3753–3762. 5 indexed citations

15.

Cruz, Carolina Colli, Sharon Lam, Patrick J. Hanley, et al.. (2013). Robust T cell responses to aspergillosis in chronic granulomatous disease: implications for immunotherapy. Clinical & Experimental Immunology. 174(1). 89–96. 7 indexed citations

16.

Bear, Adham S., Richard A. Morgan, Kenneth Cornetta, et al.. (2012). Replication-Competent Retroviruses in Gene-Modified T Cells Used in Clinical Trials: Is It Time to Revise the Testing Requirements?. Molecular Therapy. 20(2). 246–249. 45 indexed citations

17.

Kennedy, Laura C., Adham S. Bear, Joseph K. Young, et al.. (2011). T cells enhance gold nanoparticle delivery to tumors in vivo. Nanoscale Research Letters. 6(1). 283–283. 100 indexed citations

18.

Bear, Adham S., Carolina Colli Cruz, & Aaron E. Foster. (2011). T Cells as Vehicles for Cancer Vaccination. BioMed Research International. 2011(1). 417403–417403. 11 indexed citations

19.

Craddock, John, An Lu, Adham S. Bear, et al.. (2010). Enhanced Tumor Trafficking of GD2 Chimeric Antigen Receptor T Cells by Expression of the Chemokine Receptor CCR2b. Journal of Immunotherapy. 33(8). 780–788. 427 indexed citations

20.

Kaka, Anjum S., Donald R. Shaffer, Ann M. Leen, et al.. (2009). Genetic Modification of T Cells With IL-21 Enhances Antigen Presentation and Generation of Central Memory Tumor-specific Cytotoxic T-lymphocytes. Journal of Immunotherapy. 32(7). 726–736. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact